NCT03150056 2022-08-10Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerGlaxoSmithKlinePhase 1 Terminated73 enrolled 34 charts